Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anthony Alan Ramos Insider Profile
4 Followers
Anthony Alan Ramos, VP & CFO at Fresh Tracks Therapeutics, holds 146.74K shares in Fresh Tracks Therapeutics (Ticker: FRTX).
Anthony Alan Ramos has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Anthony Alan Ramos's holdings
Insider Roles
VP & CFO
Roles that Anthony Alan Ramos holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 14, 2014 - Jan 14, 2015
Return:-26.40%
The most profitable trade made by Anthony Alan Ramos
Anthony Alan Ramos's Trading History
List of latest transactions for each holding click on a transaction to see Anthony Alan Ramos's performance on stock
You May Also Like
Anthony Alan Ramos insider profile FAQ
What is the percentage of profitable transactions made by Anthony Alan Ramos?
The percentage of profitable transactions made by Anthony Alan Ramos is ―.
What is the average return per transaction made by Anthony Alan Ramos?
The average return per transaction made by Anthony Alan Ramos is ―.
What stocks does Anthony Alan Ramos hold?
Anthony Alan Ramos holds: FRTX stocks.
What was Anthony Alan Ramos’s latest transaction?
Anthony Alan Ramos latest transaction was an Uninformative Sell of $9.22K.
What was Anthony Alan Ramos's most profitable transaction?
Anthony Alan Ramos’s most profitable transaction was an Informative Buy of FRTX stock on January 14, 2014. The return on the trade was -26.40%.
What is Anthony Alan Ramos's role in Fresh Tracks Therapeutics?
Anthony Alan Ramos's role in Fresh Tracks Therapeutics is VP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.